CommercialCoverageLow impact
Genetic Testing for Lactase Insufficiency
Blue Cross & Blue Shield of Mississippi·MS · Gastroenterology, Family Medicine, Internal Medicine·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS MS has issued a new medical policy L.2.04.462 for genetic testing of lactase insufficiency as an alternative to current diagnostic methods like hydrogen breath tests and lactose tolerance blood tests. The policy provides comprehensive coverage criteria and diagnostic guidelines for commercially available genetic tests like Prometheus LactoTYPE and Fulgent Clinical Diagnostics Lab testing.
Action Required
Review new BCBS MS policy L.2.04.462 for genetic testing of lactase insufficiency to understand coverage criteria. Ensure providers are aware of the alternative diagnostic option to traditional hydrogen breath tests and lactose tolerance tests when treating patients with suspected lactose intolerance.